A Specific Role of Phosphatidylinositol 3–Kinase γ: A Regulation of Autonomic Ca2+ Oscillations in Cardiac Cells by Bony, Claire et al.
 
ã
 
 The Rockefeller University Press, 0021-9525/2001/02/717/11 $5.00
The Journal of Cell Biology, Volume 152, Number 4, February 19, 2001 717–727
http://www.jcb.org/cgi/content/full/152/4/717 717
 
A Specific Role of Phosphatidylinositol 3–Kinase 
 
g
 
: A Regulation of 
 
Autonomic Ca
 
2
 
1
 
 Oscillations in Cardiac Cells
 
Claire Bony,* Serge Roche,
 
‡
 
 Ueno Shuichi,
 
§
 
 Takehiko Sasaki,
 
i
 
 Michael A. Crackower,
 
i
 
 
 
Josef Penninger,
 
i
 
 
Hiroyuki Mano,
 
§
 
 and Michel Pucéat
 
‡
 
*The French Institute of Health and Medical Research and 
 
‡
 
the Center for Research of Macromolecular Biochemistry, 
CNRS UPR1086 Montpellier 34293, France; 
 
§
 
Division of Functional Genomics, Jichi Medical School, Tochigi, 329-04 Japan; 
 
and 
 
i
 
Amgen Institute, Ontario Cancer Institute, Department of Medical Biophysics and Immunology, Toronto, Ontario, 
MSG 2C1 Canada
 
Abstract. 
 
Purinergic stimulation of cardiomyocytes turns
on a Src family tyrosine kinase–dependent pathway that
 
stimulates PLC
 
g
 
 and generates IP
 
3
 
, a breakdown product
 
of phosphatidylinositol 4,5–bisphosphate (PIP2). This
signaling pathway closely regulates cardiac cell auto-
 
nomic activity (i.e., spontaneous cell Ca
 
2
 
1
 
 spiking).
 
PIP2 is phosphorylated on 3
 
9
 
 by phosphoinositide
3–kinases (PI3Ks) that belong to a broad family of ki-
nase isoforms. The product of PI3K, phosphatidylino-
 
sitol 3,4,5–trisphosphate, regulates activity of PLC
 
g
 
.
PI3Ks have emerged as crucial regulators of many cell
functions including cell division, cell migration, cell se-
cretion, and, via PLC
 
g
 
, Ca
 
2
 
1 
 
homeostasis. However,
although PI3K
 
a
 
 and -
 
b
 
 have been shown to mediate
speciﬁc cell functions in nonhematopoietic cells, such
a role has not been found yet for PI3K
 
g
 
.
 
We report that neonatal rat cardiac cells in culture
 
express PI3K
 
a
 
, -
 
b
 
, and -
 
g
 
. The purinergic agonist pre-
dominantly activates PI3K
 
g
 
. Both wortmannin and
LY294002 prevent tyrosine phosphorylation, and mem-
 
brane translocation of PLC
 
g
 
 as well as IP
 
3
 
 generation
in ATP-stimulated cells. Furthermore, an anti-PI3K
 
g
 
,
but not an anti-PI3K
 
b
 
, injected in the cells prevents the
 
effect of ATP on cell Ca
 
2
 
1
 
 spiking. A dominant nega-
tive mutant of PI3K
 
g
 
 transfected in the cells also exerts
the same action. The effect of ATP was observed on
spontaneous Ca
 
2
 
1
 
 spiking of wild-type but not of
PI3K
 
g
 
2/2
 
 embryonic stem cell–derived cardiomyocytes.
ATP activates the Btk tyrosine kinase, Tec, and induces
its association with PLC
 
g
 
. A dominant negative mutant
of Tec blocks the purinergic effect on cell Ca
 
2
 
1
 
 spiking.
Tec is translocated to the T-tubes upon ATP stimulation
of cardiac cells. Both an anti-PI3K
 
g
 
 antibody and a
dominant negative mutant of PI3K
 
g
 
 injected or trans-
fected into cells prevent the latter event.
We conclude that PI3K
 
g
 
 activation is a crucial step in
 
the purinergic regulation of cardiac cell spontaneous Ca
 
2
 
1
 
spiking. Our data further suggest that Tec works in concert
with a Src family kinase and PI3K
 
g
 
 to fully activate PLC
 
g
 
in ATP-stimulated cardiac cells. This cluster of kinases
provides the cardiomyocyte with a tight regulation of IP
 
3
 
generation and thus cardiac autonomic activity.
Key words: phosphoinositide kinase • calcium • ty-
rosine kinase • heart • automaticity
 
Introduction
 
Activation of phosphoinositide 3–kinase (PI3K)
 
1
 
 leads to
cell survival and proliferation, cell motility and secretion,
 
cytoskeletal rearrangement, cell migration, and Ca
 
2
 
1
 
 sig-
naling (Rameh et al., 1998; Scharenberg and Kinet, 1998;
Rameh and Cantley, 1999). These lipid/protein kinases
generate phosphatidylinositol 3,4,5–trisphosphate (PIP3)
 
after 3
 
9
 
 phosphorylation of phosphatidylinositol 4,5–
 
diphosphate (PIP2). PI3Ks belong to a broad family of
 
enzymes, grouped in class I, II, and III based on their
sequence substrate preference (PI, PIP, PI[3,4]P2, or
PI[3,5]P2). The most studied heterodimeric class I PI3K is
composed of two subgroups. PI3K of class IA
 
 
 
is a het-
erodimer consisting of a regulatory subunit (p85
 
a
 
,
 
b
 
 or
p55) associated with a catalytic subunit (p110
 
a
 
, -
 
b
 
, or -
 
d
 
)
(Fruman et al., 1998). The catalytic subunit p110
 
g
 
, which
belongs to class IB, does not bind to p85 but to a p101
adapter (Stoyanov et al., 1995; Kurosu et al., 1997). p101 is
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required for PI3K
 
g
 
 to be efficiently activated by 
 
bg
 
 sub-
units of trimeric G proteins (Leopoldt et al., 1998). Fur-
thermore, p101 confers substrate specificity of PI(4,5)P2
for the p110
 
g
 
 (Maier et al., 1999).
Whether PI3K isoforms mediate specific cell function is
just an emerging issue. p110
 
a
 
 was first shown to mediate
the effects of some growth factors on DNA synthesis
(Roche et al., 1994). A specific role of p110
 
b
 
 in mitotic sig-
nals has been then uncovered in fibroblasts (Roche et al.,
1998). A differential role of p110
 
a
 
 in cell proliferation and
survival and of p110
 
b
 
 and/or p110
 
d
 
 in migration has been
then found in macrophages (Vanhaesebroeck et al., 1999)
and in human colon carcinoma cells (Benistant et al.,
2000). In breast cancer cells, PI3K
 
a
 
 is specifically required
for EGF-induced actin rearrangement. (Hill et al., 2000).
Although PI3K
 
g
 
 is known to link serpentine receptors to
mitogen-activated protein kinase (Duckworth and Cant-
ley, 1997; Lopez-Ilasaca et al., 1997) and c-Jun NH
 
2
 
-termi-
nal kinase (Lopez-Ilasaca et al., 1998), two major cell sig-
naling pathways a specific cell function has not yet been
assigned to this isoform. Recently, gene targeted mice
lacking the p110
 
g
 
 were generated by several groups. As
expected from expression of PI3K
 
g
 
 in hematopoietic cells,
the mice featured defects in thymocyte development, T
cell activation and functions of neutrophils (Hirsch et al.,
2000; Sasaki et al., 2000a). In addition to blood cells,
Northern blot analysis revealed that mRNAs of PI3K
 
g
 
were abundant in heart, skeletal muscle, liver, and pan-
creas (Stoyanov et al., 1995). However, defects in func-
tions of these tissues were not sought in PI3K
 
g
 
2/2
 
 mice.
Although PI3Ks phosphorylate PIP2, PLCs hydrolyze
the phosphoinositides and produce IP
 
3 
 
and diacylglycerol,
the endogenous activator of protein kinase C. Activation
of a plethora of cell membrane receptors produces an ele-
vation of intracellular IP
 
3
 
, a trigger and/or regulator of
Ca
 
2
 
1
 
 oscillations or Ca
 
2
 
1
 
 waves (Berridge, 1995; Clapham,
1995). PLCs are expressed in most cell types as several iso-
forms including PLC
 
b
 
, -
 
d
 
, and -
 
g
 
. PLC
 
g
 
 is activated by ty-
rosine kinase–dependent pathways (Rhee and Bae, 1997).
There is compelling evidence that PLC
 
g
 
 activity is also in-
creased by PIP3 both directly through binding to the
pleckstrin homology (PH) (Falasca et al., 1998) and the
SH2 domains (Rameh et al., 1998) of PLC
 
g
 
 and, indi-
rectly, after activation of the tyrosine Bruton’s kinase Btk
(Li et al., 1997). PIP3 binding to the PH domain targets
PLC
 
g
 
 to the membrane. Thus, PI3Ks are at the crossroad
of a tyrosine kinase–mediated Ca
 
2
 
1
 
 signaling pathway.
We recently uncovered in cardiac cells a tyrosine kinase–
dependent Ca
 
2
 
1
 
 signaling pathway. Purinergic stimulation
of rat cardiomyocytes leads to PLC
 
g
 
 activation (Puceat
and Vassort, 1996) and in turn modulates spontaneous in-
tracellular Ca
 
2
 
1
 
 oscillations. IP
 
3
 
 generated by binding of
ATP to extracellular purinergic receptors induces a mito-
chondrial Ca
 
2
 
1
 
 loading, which indirectly depletes Ca
 
2
 
1
 
from the sarcoplasmic reticulum. This in turn slows or
stops spontaneous Ca
 
2
 
1
 
 oscillations in neonatal rat car-
diomyocytes (Jaconi et al., 2000). In cardiac cells, little is
known about expression, function, and signaling roads of
PI3Ks. To our knowledge, two studies reported an involve-
ment of p85 in leukemia inhibitory factor and angiotensin
signaling pathways in cardiomyocytes (Rabkin et al., 1997;
Oh et al., 1998). More recently, activation of a G
 
bg
 
-depen-
 
dent PI3K was shown in cardiac hypertrophy (Naga Prasad
et al., 2000). A gain of function of a mutant of p110
 
a
 
 in-
creases heart size in transgenic mice (Shioi et al., 2000).
Together, these findings prompted us to investigate the
involvement of PI3Ks in the PLC
 
g
 
-regulated Ca
 
2
 
1
 
 signal-
ing pathway in cardiomyocytes. Herein, using a pharma-
cological approach and intracellular microinjection of
specific and blocking anti-PI3Ks antibodies, as well as em-
bryonic stem (ES)–derived PI3K
 
g
 
2/2
 
 cardiomyocytes, we
provide evidence for a specific role of PI3K
 
g
 
 in cardiac
cell autonomic activity. Also, we report that Tec, a Btk
family tyrosine kinase, acts in concert with a Src family ki-
nase to support the cardiac function of PI3K
 
g
 
.
 
Materials and Methods
 
Cell Isolation and Culture
 
Cardiomyocytes were isolated from 2–3-d-old neonatal rats according to
Puceat et al. (1994) and kept in culture for 5 d.
PI3K
 
g
 
2/2
 
, PI3K
 
g
 
1/2
 
, and wild-type ES cells were cultured as previously
described (Meyer et al., 2000; Sasaki et al., 2000b). Differentiation into
cardiac cells was performed within embryoid bodies as previously de-
scribed (Meyer et al., 2000).
 
Cell Transfection
 
Cells were transfected using fugene (Boehringer) or effectene (QIAGEN)
according to the manufacturer’s instructions using a fugene/DNA ratio
(vol/wt) of 3:1 and a effectene/DNA ratio of 5:1, respectively. Cells were
cotransfected with a dominant negative mutant of Tec (kinase-dead mu-
tant; Mano et al., 1995) or a dominant negative mutant of PI3K
 
g
 
(PI3K
 
g
 
K799R) and the blue or red fluorescent protein (pEBFP or
pDsRed1-N1; CLONTECH Laboratories) to detect the transfected cells
before Ca
 
2
 
1
 
 measurement.
 
Tec Translocation
 
Cells were transfected with a TecGFP plasmid (Tec cDNA inserted in the
EcoR1 site of pEGFP-N1; CLONTECH Laboratories) alone or with a
dominant negative mutant of PI3K
 
g
 
, using effectene as described above.
pEGFP-N1 was transfected as a negative control. After 36 h, cells were
stimulated for 1 min by 20 
 
m
 
M ATP, washed with cold PBS, and then fixed
for 10 min with 3% paraformaldehyde. After washing and mounting of
coverslips in mowiol, green fluorescent protein (GFP) fluorescence was
detected with a Micromax 1300YHS charge-coupled device (CCD) cam-
era mounted on a Leica microscope.
 
Cell Immunostaining and Image Analysis
Cardiomyocytes were fixed with 3% paraformaldehyde and permeabi-
lized with 0.5% Triton X-100. Immunostaining was performed as previ-
ously described using the anti-Tec antibody and a secondary TRITC–con-
jugated anti–rabbit Ig antibody (Puceat et al., 1995). The images were
acquired with a Micromax 1300YHS CCD camera. Objectives were set on
a piezo-electric device. The images were acquired in the z direction using
a step of the piezo-electric system of 0.2 mm and stored as single TIFF im-
ages or as a volume file (“stack” of z-sections images) using the Meta-
morph software (Universal Imaging Corp.). To improve the resolution
and the signal/noise ratio of the volume data, digital deconvolution was
applied to stacks of images. The images were restored using the Huygens
software (Huygens v2.2.1; Scientific Volume Imaging) and visualized us-
ing Imaris (Bitplane). All calculations were performed using an Octane
workstation (Silicon Graphics).
Cell Fractionation
Cardiomyocytes  were washed in ice-cooled PBS for centrifugation at
1,000  g for 4 min at 48C. The pellet was thoroughly resuspended in hypo-
tonic lysis buffer, containing 10 mM Tris, 10 mM Na4P4O7, 1 mM EDTA, 1
mM MgCl2, pH 8, 10 mM NaF supplemented with 0.1 mM PMSF, and ho-
mogenized. After centrifugation, the pellet was resuspended with NET
buffer (150 mM NaCl, 5 mM EDTA, 50 mM Tris-HCl, pH 8.0) supple-Bony et al. A Specific Role of PI3Kg in Cardiomyocytes 719
mented with 1% Nonidet-P40, 50 mM NaF, 1 mM Na3VO4, 0.1 mM
PMSF, and 10 mg/ml leupeptin and kept on ice for 15 min. Myofilaments
were removed by centrifugation at 12,000 g for 20 min at 48C, and the
resulting supernatant (crude membrane fraction) was mixed with 43
Laemmli buffer and was boiled 1 min before Western analysis.
Immunoprecipitation of Proteins and Western Blotting
Whole cell lysates were subjected to immunoprecipitation as described
previously (Puceat and Vassort, 1996). The samples were run in 7.5%
SDS-PAGE and electrophoretically transferred to nitrocellulose filter.
The blots were treated as described previously (Puceat et al., 1995) and
probed with the antibody recognizing the protein of interest and a second-
ary peroxydase-conjugated antibody. The proteins were revealed using
enhanced chemiluminescence.
IP3 Measurements
Intracellular IP3 was measured with a radiobinding assay (NEN Life Sci-
ence Products) as described previously (Puceat and Vassort, 1996)
Measurement of Tyrosine Kinase Activities
Kinase activities were measured as described previously (Puceat et al.,
1998b). In brief, cardiac cell lysates prepared from control or ATP-stimu-
lated cells were subjected to immunoprecipitation using an anti-Tec anti-
body. The autophosphorylation assay was carried out in Hepes 50 mM,
MnCl2 10 mM, 1 mM DTT, 5 mCi [g-32P]ATP, and 10 mM ATP for 15 min
at 308C. The kinase reactions were stopped by adding Laemmli buffer and
heating at 1008C for 1 min. The complex was run in SDS-PAGE. After
staining and destaining, the gel was dried and exposed to autoradiography
films. Tec autophosphorylation was quantified using SCION IMAGE
software. In some experiments, the Tec immunocomplexes were split in
two fractions. Half of the immunocomplex was used for kinase activity
and half was subjected to Western blotting. The blot was probed with an
anti-PLCg or anti-PY antibody.
PI3K Activity
PI3K were immunoprecipitated from control or ATP-stimulated cells us-
ing specific antibodies. PI3K activity was measured using PI as a substrate
(Roche et al., 1998). Anti-PI3Ka and -b have been previously character-
ized (Roche et al., 1998). The polyclonal anti-PI3Kg antibody used in mi-
croinjection and immunoprecipitation experiments was raised against the
amino acids 742–756 of p110g within the Gbg and p101 binding domains
(Stoyanov et al., 1995). The monoclonal anti-PI3Kg antibody, used in
Western blot, binds to the NH2-terminal stretch (amino acids 87–302 in-
cluding the predicted PH domain) of p110g (Leopoldt et al., 1998). The
blocking activity of the polyclonal anti-PI3Kg antibody was tested in vitro.
A recombinant p110g was expressed as a glutathione S-transferase
(GST)–p110g fusion protein in Sf9 cells infected with a baculovirus and
purified (Rubio et al., 1999). Activity was then measured in vitro as de-
scribed above. p110g was decreased by 40% in two experiments in which
the specific polyclonal anti-p110g antibody was added to the kinase assay.
Anti-p110a or -p110b did not affect p110g activity (see Fig. 5 A, inset).
Microspectrofluorimetry and Imaging of Cell Ca21
Cells or embryoid bodies at days 9 and 10 were loaded with 3 or 10 mM
fluo3/AM, respectively, for 20 min and then transferred to the stage of an
epifluorescence microscope and superfused with a medium containing 20
mM Hepes, 117 mM NaCl, 5.7 mM KCl, 1.2 mM NaH2PO4, 4.4 mM
NaHCO3, 1.7 mM MgCl2, 1.8 mM CaCl2. The field was illuminated at 485 6
22 nm with a Xenon lamp. Fluo3 emission fluorescence was recorded
through a dichroic mirror (cutoff 510 nm) and a long pass emission filter
(cutoff 520 nm) as described previously (Jaconi et al., 2000). Expression of
the blue or red fluorescent protein was detected using a 360- or 515-nm
excitation filter and a dichroic mirror, respectively (cutoff 405 or 590 nm).
The fluorescence or images were recorded at 530 nm or with a 590-nm-
long pass filter, respectively, using a photomultiplier tube coupled to a di-
aphot (Nikon) microscope or a CCD camera (Hamamatsu) and digitized
on line by a computer (Metamorph software; Universal Imaging Corp.).
To plot the line scan graphs, the first image was subtracted from the other
ones (F 2 Fo) and divided by the first one to take into account fluo3 inho-
mogeneity within the cell. To calculate the frequency of Ca21 spikes in
embryoid bodies, a region of interest was selected within a beating area,
and the average intensity of pixels was plotted as a function of time (Meta-
morph software). The experiments were performed at 358C 6 28C.
Microinjection of Neonatal Rat Cardiomyocytes
Microinjection of neonatal rat cardiac cells was performed according to
Shubeita et al. (1992). The pipette concentration of antibodies was 1 mg/
ml in 150 mM KCl, 0.025 mM EGTA, 1 mM Pipes, pH 7.2. The polyclonal
anti-PI3Ks antibodies (Stoyanov et al., 1995; Roche et al., 1998) were af-
finity purified. In the experiments of microinjection of TecGFP trans-
fected cells, cells were coinjected with PI3K antibodies and rhodamine-
conjugated dextran to identify microinjected cells.
Results
A PI3K Activity Is Required in ATP-induced Activation 
of PLCg
First, we tested the effects of PI3K inhibitors on purinergic
activation of PLCg. PLCg is phosphorylated and then
translocated to the plasma membrane after ATP stimula-
tion of adult rat cardiomyocytes (Puceat and Vassort,
1996). Short purinergic stimulation of neonatal rat car-
diomyocytes plated at high density increased membrane-
associated immunoreactivity of PLCg, as previously re-
ported in adult rat ventricular myocytes (Puceat and
Vassort, 1996). In cardiomyocytes pretreated with either
wortmannin, at a concentration required to inhibit the bg-
regulated PI3K (0.5 mM) (Stephens et al., 1994) or LY
294002 (25 mM), the purinergic effect on PLCg membrane
translocation was fully abolished (Fig. 1 A). PI3K inhibi-
tors used under the same experimental conditions as the
ones described above, prevented PLCg phosphorylation,
as detected after immunoprecipitation of the lipase and
Western blotting with an antiphosphotyrosine antibody
(Fig. 1 B). We consistently observed that the phosphoryla-
tion level of PLCg was below the control value in wort-
mannin- or LY294002-treated cells. Lower concentrations
of wortmannin (0.1 mM) or LY294002 (10 mM) also par-
tially decreased ATP-induced PLCg phosphorylation and
membrane translocation (data not shown).
We then addressed whether PLCg activity was also in-
hibited by a PI3K inhibitor. Neonatal rat cardiomyocytes
stimulated with ATP for 1 min featured a twofold in-
crease in intracellular IP3 content. Cell incubation with
LY294002 fully abolished this rise and even decreased
basal content of IP3 (Fig. 1 C). This finding is consistent
with inhibition of both phosphorylation and membrane
translocation of PLCg by PI3K inhibitors.
PI3K Activity Underlies the IP3-mediated Purinergic 
Regulation of Cardiac Automatic Activity
IP3, generated by activation of purinergic P2Y receptors, is
a crucial regulator of rhythmic Ca21 spiking in neonatal rat
cardiomyocytes plated at high density. After an intracellu-
lar Ca21 release, IP3 slows or stops cell spontaneous Ca21
oscillations (Jaconi et al., 2000). We tested the effect of
PI3K inhibitors on purinergic effect in spontaneous Ca21
spiking cells. Extracellular ATP, acting through P2Y re-
ceptors slowed the rate of Ca21 spiking of fluo3-loaded
cardiomyocytes after an intracellular Ca21 release, re-
vealed by a transient rise in diastolic Ca21 (Fig. 2 A), as
described previously (Jaconi et al., 2000). In contrast, the
purinergic agonist had no effect or accelerated this rate in
cardiomyocytes treated with wortmannin or LY294002The Journal of Cell Biology, Volume 152, 2001 720
(Fig. 2, B and C). Acceleration of the rate and sustained
increase in diastolic Ca21 in the presence of ATP can be
attributed to a transient membrane depolarization after
activation of the ATP-gated ion channel through P2X re-
ceptors, an effect that is unmasked when IP3 generation by
P2Y receptors is blocked (Jaconi et al., 2000). Wortman-
nin and LY294002 added alone did not affect the rate of
Ca21 oscillations (Fig. 2 C).
Tec Is Involved in the PLCg Signaling Pathway
We showed that Fyn associates with PLCg in ATP-stimu-
lated cells (Puceat and Vassort, 1996). In hematopoietic
Figure 1. PI3K is required for ATP-induced IP3 generation. Car-
diomyocytes were stimulated with 20 mM ATP in the absence or
presence of wortmannin (Wt) or LY294002 (LY). After stimula-
tion, cells were subfractionated in cytosolic and membrane frac-
tions (A). Membrane proteins were subjected to Western blot
analysis using an anti-PLCg antibody. (B) PLCg was immuno-
precipitated, and the immunocomplex was analyzed by Western
blot using an anti-phosphotyrosine or an anti-PLCg antibody.
(C) The amount of IP3 was assayed in a protein-free cell extract.
The figure is representative of at least three experiments per-
formed on three separate cell cultures.WB, Western blotting.
Figure 2. PI3K is required for ATP-induced slowing of cell Ca21
spiking rate. A fluo3-loaded cell was superfused in the absence
(A) or presence (B) of LY294002 with 20 mM ATP. Fluo3 fluo-
rescence was recorded every 30 ms with a photomultiplier. The
figure is representative of 10 similar experiments performed us-
ing two different cell cultures. Data are compared in the bar
graph shown in (C). ^Significantly increased. (p # 0.01). ATP,
ATP-stimulated cells; C, control.Bony et al. A Specific Role of PI3Kg in Cardiomyocytes 721
cells, Btk family of tyrosine kinase was reported to be acti-
vated by PI3K in concert with Src family kinases (Li et al.,
1997). PIP3, a product of PI3K, and Btk have been in-
volved in PLCg-mediated Ca21 signaling (Scharenberg
and Kinet, 1998). Therefore, we first sought for expression
of tyrosine kinases of the Btk family in cardiac cells. Btk
has a restricted expression in hematopoietic cells and was
not found in cardiac myocytes (data not shown). A specific
anti-Tec antibody (Mano et al., 1995) detected in a cardiac
cell lysate a 58-kD protein and one upper molecular mass
variant (62 kD) of Tec, a member of the Btk family (Fig. 3
A), was previously found in T cells (Yang et al., 1999). To
further characterize the Tec immunoreactive bands found
in cardiac cell lysates, Cos cells, which lack Tec, were
transfected with a plasmid-encoding wild-type Tec. West-
ern blot analysis of a lysate from mock and transfected
Figure 3. Tec is involved in
ATP-induced slowing of cell
Ca21 spiking rate. (A) Whole
cell lysate proteins from car-
diac cells, mock Cos, or Cos
cells transfected with wild-
type Tec (from left to right
lane), were subjected to
Western blotting using an
anti-Tec antibody. (B) After
ATP stimulation, Tec was
immunoprecipitated. The
immunocomplex was used
for the autophosphorylation
assay using [g-32P]ATP in the
presence of MnCl2 and was
analyzed by autoradiogra-
phy. Cells were pretreated
for 10 min with LY294002
before ATP stimulation
(top). Data from three ex-
periments are gathered in the
line graph (middle). After
Tec immunoprecipitation, a
Western blot antiphosphoty-
rosine was performed to con-
firm the identity of the Tec
amino acid phosphorylated
after purinergic stimulation
of cells (bottom). (C) After
immunoprecipitation of Tec,
the immunocomplex was
subjected to Western blot-
ting using an anti-PLCg anti-
body to detect the presence
of PLCg. Similar experi-
ments were repeated three
times. (D) A TecGFP plas-
mid was transfected into car-
diomyocytes. 36 h later,
transfected cells were stimu-
lated (ATP) or not (control)
with 20 mM ATP. The inset
shows the labeling of a car-
diomyocyte by the anti-Tec
antibody and a secondary
TRITC-conjugated antibody.
Specificity of the labeling
was confirmed by a staining
of cardiomyocytes overex-
pressing a wild-type Tec. The
images were obtained after
digital deconvolution (Huy-
gens software) and visualized
using a shadow projection (Imaris software). In this series of experiments 85 6 5% of cells featured a membrane staining of TecGFP
(E), mock cells or cells transfected with a dominant negative (DN) mutant of Tec were loaded with fluo3 and superfused with ATP.
Fluo3 fluorescence was recorded in a region of interest including the whole cell with a CCD camera. Two to three images/s were cap-
tured by a CCD camera. A similar result was obtained in 12 cells isolated from two separate cultures as shown in the bar graph. *Signif-
icantly decreased; ^significantly increased (p # 0.01). wt, Wild-type; ATP, ATP-stimulated cells; C, control.The Journal of Cell Biology, Volume 152, 2001 722
cells revealed that wild-type Tec encodes a protein migrat-
ing with an apparent molecular weight of 58–60 kD, simi-
lar to the main Tec immunoreactive protein found in car-
diac cells. Using both autophosphorylation of the kinase
and antiphosphotyrosine Western blotting after Tec im-
munoprecipitation as an index of activation, we found that
purinergic stimulation of cardiomyocytes induced within 1
min and for $5 min, a two- to threefold increase in Tec au-
tophosphorylation as shown by a labeled band migrating
at 60 kD (Fig. 3 B). This activation was accompanied with
an association of the kinase with PLCg (Fig. 3 C), which
suggested that Tec may be translocated to the cell mem-
brane upon cell stimulation with ATP. Tyrosine phosphor-
ylation of Tec was detected in the Tec immunocomplex in
a Western blot using an antiphosphotyrosine antibody
(Fig. 3 B). Both Tec autophosphorylation and association
with PLCg were inhibited by cell treatment with the PI3K
inhibitor LY2940002. (Fig. 3, B and C). To test whether
Tec may be translocated to the membrane upon ATP cell
stimulation, cardiomyocytes were transfected with a plas-
mid encoding a GFP-tagged Tec. TecGFP was homoge-
neously distributed throughout the cytosol and in the nu-
cleus under resting conditions as the endogenous Tec was
revealed by the anti-Tec antibody (Fig. 3 D, inset). Short
ATP stimulation (1 min) of cells induced a translocation of
TecGFP to the T-tubes (i.e., plasma membrane invagina-
tions) of cardiac cells, as revealed by the regular rib-like
GFP staining (Fig. 3 D). To investigate whether Tec may,
like Btk, regulate PLCg function and thus Ca21 signaling,
we tested the effect of expression of a dominant negative
mutant of Tec lacking the kinase domain (Yamashita et
al., 1998) on IP3-regulated cell automatic Ca21 spiking. In
cells expressing the dominant negative mutant of Tec,
ATP had no effect or increased the rate of Ca21 spiking,
whereas it stopped the spontaneous Ca21 spikes in mock
cells, a hallmark of IP3 action (Fig. 3 E).
The Purinergic Agonist Specifically Activates
p110 PI3Kg
Next, we investigated expression of PI3Ks isoforms in neo-
natal rat cardiac cells. Using specific antibodies directed
against the adapter p85 or the catalytic subunits p110a, -b,
or -g, the proteins were immunoprecipitated from a cardiac
cell lysate and then immunoblotted with an anti-p110 anti-
body. p110a, -b, and -g are all expressed in cardiac cells
(Fig. 4 A). We further addressed whether all PI3K isoforms
were activated by purinergic stimulation of cardiac cells.
Cells were stimulated for 0.5, 1, and 5 min, and the catalytic
p110 subunit was immunoprecipitated from cell lysates.
PI3K activities, assayed in the immunocomplexes, revealed
that ATP mainly and rapidly increased p110g activity as re-
vealed by Phosphorous-32 labeling of PIP. Maximal activa-
tion was reached within 0.5 min. p110b activity was slightly
but more sustainely increased in ATP-stimulated cells.
Basal activity of PI3Ka was high but barely affected by pu-
rinergic stimulation of cardiomyocytes (Fig. 4 B).
p110g but Not p110b Is Required for IP3-mediated 
Purinergic Effect on Cell Ca21 Spiking and for Tec 
Membrane Translocation
PI3K inhibitors prevented ATP from slowing the rate of
cell Ca21 spiking. Both p110b and p110g activities were
significantly activated by ATP. We thus designed microin-
jection experiments to identify the PI3K isoform that un-
derlies this effect. To reach such an aim, antibodies spe-
cific of PI3K isoforms were injected into rhythmic Ca21
spiking cardiomyocytes, and the effect of ATP was further
tested. In cells injected with an anti-p110b antibody, ATP
induced a transient release in intracellular Ca21 and then
slowed and stopped spontaneous cell Ca21 spiking (n 5 9
cells), as previously found in noninjected cells (Fig. 2) (Ja-
coni et al., 2000). In contrast, in cells injected with a spe-
cific and blocking (Fig. 5 A, inset) anti-p110g antibody
(n 5 11 cells), ATP did not induce an intracellular Ca21
release and transiently accelerated spontaneous Ca21 spik-
ing (Fig. 5 A). Expression of a dominant negative mutant
of PI3Kg (K399R) that lacks lipid kinase activity (Stoy-
anova et al., 1997) in the cells also significantly prevented
the slowing effect of ATP on cell Ca21 spiking (Fig. 5 A).
To further test the involvement of PI3Kg in the ATP ef-
fect on cell Ca21 spiking, we used PI3Kg2/2 ES cells to gen-
Figure 4. ATP specifically activates PI3Kg. (A) PI3K subunits p85,
p110a, -b and -g were immunoprecipitated from a cardiac whole
cell lysate and subjected to Western blot analysis using either an
anti-p110 a1, b3, or g antibody. The polyclonal anti-p110g anti-
body was used for the immunoprecipitation and the monoclonal
anti-p110g antibody was used for Western blot. (B) Cells were
stimulated for 0, 0.5, 1, or 5 min with 20 mM ATP, and PI3 kinase
activity was assayed after PI3K immunoprecipitation. The experi-
ment was repeated at least three times on three separate cultures.
Means 6 SEM of fold activation of PI3Ks are plotted as a function
of the duration of purinergic stimulation of cells after scanning the
autoradiographic films exposed to TLC plates (bottom).Bony et al. A Specific Role of PI3Kg in Cardiomyocytes 723
erate cardiomyocytes within embryoid bodies (Meyer et al.,
2000). At day 9 of differentiation, 80% of PI3Kg2/2,
PI3Kg1/2, or wild-type embryoid bodies (n 5 25) featured
several spontaneously beating areas, showing that ES cells
differentiated into contractile cardiomyocytes (Meyer et al.,
2000; Sasaki et al., 2000b). At this stage of differentiation
(day 9), functional type I IP3 receptors (Kolossov et al.,
1998) are already strongly expressed in cardiomyocytes and
distributed mainly around the nucleus and in a network
spreading from the nuclear area (data not shown), as found
in neonatal myocytes (Jaconi et al., 2000). In contrast, ryan-
odine receptors are still poorly expressed in ES-derived car-
diomyocytes (Meyer et al., 2000), a situation also similar to
neonatal cardiomyocytes. Furthermore, spontaneous beat-
ing activity of embryoid bodies (i.e., automaticity) is closely
dependent on intracellular Ca21 (Viatchenko-Karpinski et
al., 1999). In fluo3-loaded wild-type or PI3Kg1/2 embryoid
bodies, ATP significantly slowed down the spontaneous
Ca21 spiking of cardiomyocytes. This effect was not ob-
served in PI3Kg2/2 embryoid bodies (Fig. 5 B)
Also, we looked at the effects of anti-PI3K antibodies
on TecGFP membrane translocation. In cells transfected
with TecGFP and microinjected with an anti-PI3Kb anti-
body, ATP still triggered a membrane translocation of
Tec, as revealed by the regular labeling of T-tubes. By
contrast, in cells microinjected with an anti-PI3Kg anti-
body, Tec remained in the cytosol after a 1-min purinergic
stimulation (Fig. 5 C), as also seen in cells pretreated for
10 min with 20 mM LY294002 (data not shown). In cells
transfected with a dominant negative mutant of PI3Kg
(K399R),  ATP did not trigger Tec translocation to the
membrane (Fig. 5 C).
Discussion
We found that cardiac cells express several PI3Ks of class I
including PI3Kg and that activity of the latter, together
with the tyrosine kinase Tec, is required to mediate the pu-
rinergic effect on autonomic Ca21 spiking of neonatal rat
cardiomyocytes.
Both inhibitors of PI3Ks, wortmannin and LY294002,
used for a short time (10 min) at concentrations (0.1 or 0.5
and 20 mM, respectively) that inhibit the Gbg-regulated
PI3K (Stephens et al., 1994) prevent both phosphorylation
and translocation of PLCg to the membrane of cardiac
cells. Definite evidence in favor of a requirement of PI3K
activity for PLCg activation is brought by the IP3 measure-
ment assay. Indeed, PI3K inhibitors fully blocked ATP-
induced IP3 generation. Wortmannin also inhibits PI4K, a
kinase required for the synthesis of PIP2. A limitation of
this substrate may decrease IP3 formation. However,
LY294002 also prevents IP3 formation at a concentration
far below the one that inhibits PI4K (Downing et al.,
1996). Thus, we propose that PI3K is mandatory to turn on
the PLCg-dependent IP3 pathway in purine-stimulated
cells.
Previously, we showed that tyrosine phosphorylation is
a key step for purinergic activation of PLCg in cardiac
cells (Puceat and Vassort, 1996). Our current findings indi-
cate that PIP3, the product of PI3K, is also necessary to ac-
tivate the phospholipase. PIP3 is likely to provide a mem-
brane anchoring site for the PH domain of PLCg (Falasca
et al., 1998). We found that LY294002 not only inhibits
ATP-induced IP3 production but also decreases the basal
level (Fig. 1 C). Also, we observed such an effect of the
drug on IP3 generation in wortmannin-treated cells and on
PLCg membrane translocation and phosphorylation in
both LY294002- and wortmannin-treated cells. This sug-
gests that cardiac cells feature a tonic activation of PI3K as
previously found in Cos cells (Wennstrom and Downward,
1999). This may be in part responsible for a high phospho-
inositide turnover and in turn for the high masses of en-
dogenous IP3 in these cells (Fig. 1 C). In agreement with
our findings on IP3 generation, PI3Ks inhibitors prevent
the effect of ATP on autonomic Ca21 spiking, an effect
mediated by IP3 (Jaconi et al., 2000). Our present data
demonstrate that activation of PI3K, together with PLCg,
is required for ATP-induced IP3 formation and, in turn,
regulation of Ca21 spiking in primary culture of cardio-
myocytes. This is in line with observations reported in the
HepG2 cells in which PI3K mediates PDGF-induced in-
tracellular Ca21 release (Rameh et al., 1998).
Extracellular ATP predominantly activates PI3Kg and,
to some but much less extent, PI3Kb but only barely af-
fects PI3Ka whose basal activity is already high in cardiac
cells (Fig. 3). The relative extent of purinergic activation
of PI3K isoforms may be taken with caution. In vitro
PI3Ks activity using a phosphoinositol as a substrate may
be different from the in vivo situation in which membrane
phospholipids are more complex. Substrate specificity of
PI3K isoforms may also differ in vivo compared with the
in vitro assays. It is interesting to note that purinergic acti-
vation of PI3Kg was not only much stronger but also more
transient than the one of PI3Ka and -b. This suggests that
PI3Kb and -a may be involved in more time lasting cell
events such as cell survival or cell hypertrophy (Shioi et
al., 2000), whereas PI3Kg mediates short-term regulation
of cardiac autonomic activity.
However, we also found that microinjection of an anti-
PI3Kg antibody into cardiomyocytes prevents the slowing
effect of ATP on autonomic cell Ca21 oscillations. In these
microinjected cells, ATP increases the rate in cells in
which the IP3-dependent pathway was disrupted, as previ-
ously observed (Jaconi et al., 2000) (Fig. 2 B). Such an in
vivo blocking effect of the anti-PI3Kg antibody could be
expected. First, the specificity of the antibody has been re-
cently confirmed by the absence of any cross-reactivity
with other PI3Ks in PI3Kg2/2 mice (Sasaki et al., 2000b).
Second, this antibody partially blocks p110g activity in in
vitro assay. Finally, the antibody recognizes the region of
PI3Kg that binds both p101 and Gbg (Leopoldt et al.,
1998), which most likely accounts for the neutralizing in
vivo effect. In contrast, in cardiomyocytes injected with an
anti-PI3Kb antibody, ATP still slows the rate of Ca21 spik-
ing after triggering an intracellular Ca21release, a hall-
mark of IP3 action. This further demonstrates that PI3Kg
is mandatory for ATP-induced PLCg activation. In this
study, we used a powerful approach of microinjection of
PI3K antibodies, whose isoform specificity has been pre-
viously demonstrated (Stoyanov et al., 1995; Roche et al.,
1998). This approach, already successful in cardiac cells
(Puceat et al., 1998b), was first chosen herein because it is
more reliable and more specific than the use of kinase
dead mutants of p110PI3Ks. The latter may partially inter-The Journal of Cell Biology, Volume 152, 2001 724
fere with other isoforms with their regulatory subunits,
as recently demonstrated (Vanhaesebroeck et al., 1999).
However, we confirmed the findings obtained with the
antibody using two other experimental approaches. A
dominant negative mutant of PI3Kg, expressed in neo-
natal cardiomyocytes, blocks the effect of ATP on both
Ca21 spiking and Tec membrane association. In sponta-
neously beating cardiomyocytes generated from PI3Kg2/2
ES cells, ATP did not affect the frequency of Ca21 spik-
ing whereas it significantly decreased it in embryoid
bodies generated from PI3Kg1/2 or wild-type ES cells,
as observed in neonatal cardiomyocytes. Together, our
findings demonstrate that PI3Kg mediates purinergic ac-
tivation of PLCg, subsequent IP3 formation, and modu-
lation of spontaneous cell Ca21 spiking in cardiac cells.
To our knowledge, ATP is the first agonist, binding to a
Figure 5. PI3Kg mediates
both ATP-induced slowing of
cell Ca21  spiking and Tec
translocation to the cell mem-
brane. (A) Cardiomyocytes
were microinjected with a
specific anti PI3Kb or -g
polyclonal antibody together
with fluo3. Cell Ca21 spiking
was monitored with a CCD
camera. After background
subtraction, a line was set
offline along a cell (arrow).
Fluorescence was recorded
along the line as a function of
time. The line scan images of
adjacent lines were recon-
structed using ANALYZE
software (Mayo Foundation).
The graphs below the images
represent the change in fluo-
rescence (DF) along the time
after subtraction of the first
image (Fo). Similar results
were obtained on at least 10
cells from two separate cell
cultures as shown in the bar
graph on the left. Cells were
also transfected with a
dominant negative mutant
(K399R) of PI3Kg, and the
effects of ATP on cell Ca21
spiking was measured 24 h
later on 10 different cells
from two separate cultures
(right). A recombinant p110g
was expressed as a GST-
p110g fusion (inset). PIP3K
activity was then measured in
vitro in the presence of rabbit
IgG, the specific polyclonal
anti-p110g, or the anti-p110a
or -p110b antibodies. (B)
Beating embryoid bodies
(days 9 and 10) generated
from PI3Kg2/2, PI3Kg1/2, or
wild-type (WT) ES cells were
loaded with fluo3, and the ef-
fect of ATP was tested on
spontaneous Ca21 spiking of
cardiomyocytes. The results
are expressed as means 6 SEM from 15 PI3Kg2/2, 6 PI3Kg1/2, and 6 wild-type embryoid bodies. (C) A specific anti-PI3Kb (left) or g an-
tibody (middle) was injected, or a dominant negative mutant (K399R) of PI3Kg was transfected into cells (right). Cardiomyocytes trans-
fected with a TecGFP plasmid were microinjected. 1 h later, cells were stimulated for 1 min with ATP and fixed before image acquisition.
Similar results were obtained in 15 cells from three separate cell cultures, as shown in the bar graph on left. Cells were also transfected
with a dominant negative mutant (K399R) of PI3Kg, and the effects of ATP on Tec membrane translocation was tested on eight trans-
fected or mock cells (right). *Significantly decreased; ^significantly increased (p # 0.01). ATP, ATP-stimulated cells; C, control.Bony et al. A Specific Role of PI3Kg in Cardiomyocytes 725
serpentine receptor, to activate a specific isoform of
PI3K and the first agonist to activate PI3Kg in excitable
cells.
Previously, we reported that Src family kinases mediate
the effects of ATP on both PLCg activity (Puceat and Vas-
sort, 1996) and Ca21 signaling (Jaconi et al., 2000). Herein,
we show that, in response to extracellular ATP, Tec, the ty-
rosine kinase of the Btk family, is phosphorylated and
translocated into the T-tubes, plasma membrane invagina-
tion in cardiomyocytes (Figs. 3 and 5). Tec also associates
with PLCg in ATP-stimulated cardiomyocytes (Fig. 3) and
is a key element in the regulation of cell Ca21 spiking by
Figure 5 (continued)The Journal of Cell Biology, Volume 152, 2001 726
ATP (Fig. 3). These data further suggest that Tec is likely
to be transphosphorylated by Src family kinases, activated
as demonstrated for other members of the Btk family
(Mahajan et al., 1995; Rawlings et al., 1996).  Since Tec
membrane translocation depends on PI3Kg activation, as
revealed by the inhibitory effect of intracellular microin-
jection of a specific and blocking anti-PI3Kg antibody (Fig.
5), PIP3 is likely to anchor at the cell membrane, not only
PLCg but also the tyrosine kinase Tec, through its PH do-
main (August et al., 1997; Varnai et al., 1999). These data
also argue in favor of ATP-induced PLCg activation, medi-
ated by Src/Tec tyrosine kinases, together with PI3K (Au-
gust et al., 1997).
Together, our findings obtained in excitable cells sup-
port the idea that a cluster of kinases comprising Btk and
Src family kinases as well as PI3Kg and PLCg constitute
a regulatory network of intracellular Ca21 homeostasis
(Scharenberg and Kinet, 1998). Such a multistep process
in which two families of tyrosine kinases are implicated
has been previously reported for T cell activation (August
et al., 1997) and for cell spreading (Meng and Lowell,
1998). It is likely that the purinergic receptor is coupled to
a Gs protein, as previously found (Puceat et al., 1998a).
Activation of this receptor by ATP leads to dissociation of
as and bg subunits. as is likely to directly activate Fyn and
Src (Ma et al., 2000), whereas bg activates PI3Kg. In car-
diac cells, this regulatory nexus between Fyn, Tec, and
PI3Kg constitutes an amplification cascade to ensure a fast
but transient accumulation of IP3 (Fig. 6). It also provides
the heart with a fine regulation of a critical cell function,
namely cell autonomic activity, by factors that activate a
tyrosine kinase–dependent pathway.
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